[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Articles archive::
All Issues
Current Issue
Browse by Authors
Browse by Keywords
For Authors::
Call for Papers
Submission Instruction
Submission Form
For Reviewers::
Reviewers Section
Registration::
Registration Information
Registration Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
Indexing & Abstracting::
Publication Ethics::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing & Abstracting
DOAJ
GOOGLE SCHOLAR
..
:: Volume 28, Issue 4 (7-2023) ::
__Armaghane Danesh__ 2023, 28(4): 565-578 Back to browse issues page
Investigating the Epidemiological Trend of COVID-19 Disease in Kohgiluyeh and Boyer Ahmad Province, Iran
A Mousavizadeh1 , M Behnampur1 , R Alaei1 , H Askarpour1 , S Darabi1 , H Faghihi2
1- Research Center for Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, Iran.
2- Research Center for Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, Iran. , sayedhasanfaghihi2016@yahoo.com
Abstract:   (1342 Views)
Background & aim: The Covid-19 pandemic has presented the world with a wide array of economic, social, political, and health problems. Therefore, providing people with correct and timely information can significantly help disease management and reduce death cases. The present study aimed to assess the epidemiology of Covid-19 in Kohgiluyeh and Boyer-Ahmad Province. 

Methods: The current study descriptive study of the epidemic trend was carried out in 2022. The data was collected by reviewing the valid information collected in the academic headquarters of the control of Kogilouye and Boyer Ahmad province, Iran, and the systems related to this disease in the period of 33 months after the first confirmed case of the disease was identified in the province. The collected data were analyzed using descriptive statistics including mean and frequency percentage.

Results: With the removal of travel restrictions, there was an increase in disease cases in the province. The incidence rate and percentage of positive Covid-19 cases in Kohgiluyeh and Boyer-Ahmad province were much higher than the national average. The highest percentage of positive rate in the samples was associated to the month of November 2019 with 56.59% nonetheless the percentage of case fatality rate caused by the disease in the province is lower than the national average (.86 against 1.91 percent). The percentage of Covid-19 related deaths in the province was lower than the national average. At the same time, with an increase in vaccination coverage and the percentage of infection in the province, a decrease in cases of infection, hospitalization, and Covid-19-related death were observed. The comparison of the first and last peaks of the disease in the province demonstrates the marked effect of vaccination.

Conclusion: Encouraging and persuading the community about the importance of vaccination, especially the third round and also the injection of the fourth dose of the Covid-19 vaccination, with the priority of health system personnel and people with underlying diseases, using the capacity of other institutions and organizations, especially the radio and television of the provincial capital is the safest and most optimal means of protection against infection, hospitalization and death caused by Covid-19.

 
Keywords: Epidemiology, Trend, Covid-19, Kohgiluyeh and Boyer-Ahmad
Full-Text [PDF 490 kb]   (315 Downloads)    
Type of Study: Research | Subject: Epidemiology
Received: 2023/01/19 | Accepted: 2023/04/15 | Published: 2023/07/10
References
1. Tavakoli A, Vahdat K, Keshavarz M. Novel coronavirus disease 2019 (COVID-19): an emerging infectious disease in the 21st century. ISMJ 2020; 22(6): 432-50. ## [DOI:10.29252/ismj.22.6.432]
2. MacKenzie D. Covid-19 goes global. Elsevier: Available; 2020; 35-7. From:https://www.sciencedirect.com/science/article/pii/S0262407920304243. ##
3. Mirmohammadkhani M, Paknazar F, Rashidy-pour A L. Evaluation of the epidemiological pattern of COVID-19 applying basic reproduction number: An educational review article. Koomesh 1399; 22(3): 373-9. ## [DOI:10.29252/koomesh.22.3.373]
4. Chen D, Zhou T. Control efficacy on COVID-19. ArXiv Preprint ArXiv 2003; 00305: 2020. ##
5. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology 2020; 296(2): E15-25. ## [DOI:10.1148/radiol.2020200490] [PMID] []
6. Organization WH. Weekly epidemiological update on COVID-19 - 21 December 2022. 2022. ##
7. Barber RM, Sorensen RJ, Pigott DM, Bisignano C, Carter A, Amlag JO, et al. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021; a statistical analysis. The Lancet 2022; 399(10344): 2351-80.##
8. Golpour M, Valadan R, Zargari M, Mousavi T. Review of the major SARS-CoV-2 mutations in different variants and their function. Journal of Mazandaran University of Medical Sciences 2021; 31(200): 187-98.##
9. Kashani A, Mehr M, Elkhichi P. Challenges of laboratory sampling and diagnosis of SARS-CoV-2 virus of disease (COVID-19). Urmia Medical Journal 2021; 32(3): 156-74. ##
10. Education MoHaM. National program to establish and expand immunization of Covid 19 in Iran, Tehran. ##
11. Heidari M, Jafari H. Challenges of COVID-19 vaccination in Iran: In the fourth wave of pandemic spread. Prehospital and Disaster Medicine 2021; 36(5): 659-60. ## [DOI:10.1017/S1049023X21000777] [PMID] []
12. Bagheri Sheykhangafshe F, Fathi-Ashtiani A. Priority of the elderly and patients with chronic diseases in COVID-19 vaccination: Letter to Editor. Journal of Birjand University of Medical Sciences 2021; 28(3): 302-6. ## [DOI:10.32592/JBirjandUnivMedSci.2021.28.3.109]
13. Miles LW, Williams N, Luthy KE, Eden L. Adult vaccination rates in the mentally ill population: an outpatient improvement project. Journal of the American Psychiatric Nurses Association 2020; 26(2): 172-80.## [DOI:10.1177/1078390319831763] [PMID]
14. Bagheri Sheykhangafshe F. COVID-19 Vaccination: challenges and opportunities. Journal of Rafsanjan University of Medical Sciences 2022; 20(11): 1289-94. ## [DOI:10.52547/jrums.20.11.1289]
15. Kolozsvari LR, Bérczes T, Hajdu A, Gesztelyi R, Tiba A, Varga I, et al. Predicting the epidemic curve of the coronavirus (SARS-CoV-2) disease (COVID-19) using artificial intelligence. MedRxiv 2021; 2020: 22: 2020-04.## [DOI:10.1101/2020.04.17.20069666]
16. Murray CJ, COVID-19 will continue but the end of the pandemic is near. The Lancet 2022; 399(10323): 417-419. ## [DOI:10.1016/S0140-6736(22)00100-3] [PMID]
17. Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study. The Lancet 2022; 399(10332): 1303-1312.## [DOI:10.1016/S0140-6736(22)00462-7] [PMID]
18. Wan J, Cazer CL, Clarkberg ME, Henderson SG, Lee SE, Meredith G, et al. Boosters protect SARS-CoV-2 infections in young adults during an Omicron-predominant period. medRxiv, 2022. ##
19. Chemaitelly H, Ayoub H, AlMukdad S, Coyle P, Tang P, Yassini HM, et al. Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar :a retrospctive cohort study. Lancet microb 2022; 3(12): e944-e955. ## [DOI:10.1016/S2666-5247(22)00287-7] [PMID]
20. Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernán MA, et al. Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine 2022; 386(17): 1603-1614.## [DOI:10.1056/NEJMoa2201688] [PMID] []
21. Arbel RR, Sergienko M, Friger A, Peretz T. Beckenstein S . Second booster vaccine and covid-19 mortality in adults 60 to 100 years old. Preprint from Research Square, 2022. ## [DOI:10.21203/rs.3.rs-1478439/v1]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mousavizadeh A, behnampur M, alaei R, askarpour H, darabi S, faghihi H. Investigating the Epidemiological Trend of COVID-19 Disease in Kohgiluyeh and Boyer Ahmad Province, Iran. armaghanj 2023; 28 (4) :565-578
URL: http://armaghanj.yums.ac.ir/article-1-3426-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 28, Issue 4 (7-2023) Back to browse issues page
ارمغان دانش Armaghane Danesh
Persian site map - English site map - Created in 0.07 seconds with 39 queries by YEKTAWEB 4710